Cyclo(RGDyC) TFA

• CAT Number: I040197
• Molecular Formula: C24H34N8O8S.xC2HF3O2
• Molecular Weight: 594.64 (free base)
• Purity: ≥95%

Cyclo(RGDyC) TFA is a cyclic pentapeptide with anti-angiogenic abilities. Cyclo(RGDyC) TFA can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer[1][2].

Reference

[1]. Lu Y, et al. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting. Nanotechnology. 2013 Apr 5;24(13):135101.
 [Content Brief]

[2]. Tang M, et al. Photostable and Biocompatible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultaneous Imaging and Treatment of Ocular Neovascularization. Anal Chem. 2018 Jul 3;90(13):8188-8195.
 [Content Brief]